AVADEL PHARMACEUTICALS-ADR
Engaged in the research and development of pharmaceutical products for the treatment of sleep disorders
Stock Performance Snapshot
Analyst Rating
Analysts suggest buying Avadel Pharmaceuticals' stock, anticipating a price increase to $21.22.
Financial Health
Avadel Pharmaceuticals is generating average revenue and cash flow, with strong gross margins indicating efficient operations.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring AVDL
The Global Weight-Loss Drug Price Shift
Eli Lilly's significant price hike for Mounjaro in the UK, driven by U.S. political pressure, highlights a new global pricing strategy for blockbuster drugs. This creates a potential opportunity for competitors in the booming weight-loss market as patients and providers may seek more affordable alternatives.
Published: August 15, 2025
Explore BasketNext-Generation Drug Delivery Systems
This carefully selected group of stocks represents innovative companies revolutionizing how medications are delivered to patients. Handpicked by our professional analysts, these firms are developing technologies that make treatments simpler, more effective, and user-friendly, creating meaningful investment potential in an evolving healthcare landscape.
Published: July 18, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Pipeline-driven growth
Late-stage clinical readouts and approvals can materially move the story, though outcomes are uncertain and can cause volatility.
Speciality market focus
Targeting rare and sleep disorders can mean concentrated market opportunities, but commercial success depends on uptake and payer support.
Regulatory catalysts
Upcoming regulatory milestones and launches are potential catalysts, balanced by the risk of delays or unfavourable decisions.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Eli Lilly and Company
Eli Lilly & Co is a global pharmaceutical company that develops, manufactures and markets human prescription drugs.
Johnson & Johnson
Johnson & Johnson is a multinational conglomerate pharmaceutical, medical devices, and consumer packaged goods company.
AbbVie Inc.
Abbvie is a research-based biopharmaceutical company that develops and markets advanced therapies to address complex medical conditions.
